Unknown OBSERVATIONAL NCT05144165

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines Using Delphi Consensus Statement

Sponsor: Centre of Evidence of the French Society of Dermatology

Conditions Psoriasis Psoriasis Guttate Psoriasis Inverse Psoriasis Palmaris Psoriasis Pustular Psoriasis Universalis Psoriasis Vulgaris Psoriasis of Scalp Psoriatic Erythroderma Psoriatic Nail Psoriatic Plaque

Interventions Experts consensus

Updated 4 times since 2022 Last updated: Nov 21, 2021 Started: Nov 8, 2021 Primary completion: Mar 31, 2022 Completion: Mar 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05144165, this observational or N/A phase trial focuses on Psoriasis and Psoriasis Guttate and remains ongoing. Sponsored by Centre of Evidence of the French Society of Dermatology, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2022 — Dec 2023 [monthly]

Recruiting

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre of Evidence of the French Society of Dermatology

Data source: Centre of Evidence of the French Society of Dermatology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France